1[1]Jin Najia, Rafat A, Denis E, et al. Communication between tyrosine kinase pathway and myosin light chain kinase pathway in smooth muscle. American Physiology, 1996, 271(4 part 2): H1348
3[3]Sharpe T R, Vasios G W. PTK inhibitors for treating osteoarthritis. PCT Int Appl WO 97, 1997, Apr: 11692,3
4[4]Traxler P M, Marc L. PTK inhibitors in cancer treatment. Expert Opin Ther Pat, 1997, 7(6): 571
5[5]Trazler P M, Furet P, Marc L, et al. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of ATP-binding site of the EGFR. J Pharm Belg, 1997, 52(2): 88
6[6]Traxler P M, Bold G, Frei J, et al. Use of a pharmacophore model for the design of EGFR tyrosine kinase inhibitors: 4(phenylamino) pyrazolo-[3,4-d] pyrimidines. J Med Chem, 1997, 40(22): 3601
7[7]Gordon W, Alexander J B, David W F, et al. PTK inhibitors 12 synthesis and structure-activity relationships for 6-substituted 4-(phenylamino) pyrimido [5,4-d] pyrimidines designed as inhibitor of the EGFR. J Med Chem, 1997, 40(12): 1820
8[8]Thompson A M, Alexander J B, David W F, et al. Tyrosine kinase inhibitor 7,7-amino-4(phenylamino)-and 7-amino-4-[(phenylmethyl)amino] pyrido [4,3-d]-primidines; a new class of inhibitor of the tyrosine kinase activity of the EGPR. J Med Chem, 1995, 38(19): 3780-8
9[9]Zhu Jiangyum, Shore S K c-ABLtyrosine kinase activity is regulated by association with a novel SH3-domain-binding protein. Mol Cell Biol, 1996, 16(12): 7054
10[10]Nishi T, Budde R J A, John S, et al. Tight-binding inhibitory sequences against pp60c-Src identified using a random 15-amino acid peptide. FEBS Lett, 1996, 399(3): 237
4Kyle E,Neckers L,Takimoto C,et al.Genistein induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity[J].Mol Pharmacol,1997,51(2):193-200.
5Okabe L,Yoshida E,Chieda S,et al.BE-23372M,a novel protein tyrosine kinase inhibitor.I.Producing organism,fermentation,isolation and biological activities[J].J Antibiot (Tokyo),1994,47(3):289-293.
6Cassinelli G,Lanzi C,Pensa T,et al.Clavilactones,a novel class of tyrosine kinase inhibitors of fungal origin[J].Biochem Pharmacol,2000,59:1539-1547.
7Sadeghi R,Depledge P,Rwlins P,et al.Differential regulation of CD3-and CD28-induced IL-2 and IFN-γ production by a novel tyrosine kinase inhibitor XR774 from Cldosporium cf.cladosporioides[J].Int Immunopharmacol,2001.1:33-48.
8Oyama M,Xu Z,Lee KH,et al.Fungal metabolites as potent protein kinase inhibitors:identification of a novel metabolite and novel activities of known metabolites[J].Lett Drug Design Discovery,2004,1:24-29.
